Grass and Acute biphenotypic leukaemia - from FDA reports


Summary

There is no Acute biphenotypic leukaemia reported by people who take Grass yet. This review analyzes which people have Acute biphenotypic leukaemia with Grass. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Grass and have Acute biphenotypic leukaemia, find out what symptoms you could have in 1 year or longer.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Nov, 18, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Acute biphenotypic leukaemia when taking Grass?

Expand the study to include all drugs with the same ingredients

Acute biphenotypic leukaemia and drugs with ingredients of marijuana.

Expand the study to include reports from both FDA and eHealthMe

Acute biphenotypic leukaemia and Grass from FDA and eHealthMe reports

Grass

Grass has active ingredients of marijuana.

Acute Biphenotypic Leukaemia

Acute biphenotypic leukaemia (leukaemia where the lineage is of both lymphoid and myeloid origin) has been reported by people with endometrial cancer, endometrial cancer stage iv, acute myeloid leukaemia recurrent, essential thrombocythaemia, acute graft versus host disease (latest reports from 95 Acute biphenotypic leukaemia patients).

Browse all side effects of Grass

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Acute biphenotypic leukaemia

Acute biphenotypic leukaemia

Could your condition cause Acute biphenotypic leukaemia

Acute biphenotypic leukaemia

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Grass and have Acute biphenotypic leukaemia.